A detailed history of Congress Asset Management CO transactions in Amgen Inc stock. As of the latest transaction made, Congress Asset Management CO holds 54,093 shares of AMGN stock, worth $16.8 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
54,093
Previous 56,284 3.89%
Holding current value
$16.8 Million
Previous $16.2 Million 5.13%
% of portfolio
0.11%
Previous 0.13%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024

SELL
$268.87 - $324.56 $589,094 - $711,110
-2,191 Reduced 3.89%
54,093 $15.4 Million
Q4 2023

Mar 04, 2024

SELL
$255.7 - $288.46 $549,499 - $619,900
-2,149 Reduced 3.68%
56,284 $16.2 Million
Q3 2023

Nov 01, 2023

BUY
$218.65 - $271.46 $297,364 - $369,185
1,360 Added 2.38%
58,433 $15.7 Million
Q2 2023

Jul 27, 2023

SELL
$214.27 - $253.37 $45,425 - $53,714
-212 Reduced 0.37%
57,073 $12.7 Million
Q1 2023

Apr 21, 2023

BUY
$225.79 - $275.2 $222,177 - $270,796
984 Added 1.75%
57,285 $13.8 Million
Q4 2022

Jan 18, 2023

BUY
$229.03 - $291.01 $196,736 - $249,977
859 Added 1.55%
56,301 $0
Q3 2022

Nov 08, 2022

BUY
$224.46 - $253.15 $295,838 - $333,651
1,318 Added 2.44%
55,442 $12.5 Million
Q2 2022

Aug 02, 2022

BUY
$230.71 - $256.74 $151,115 - $168,164
655 Added 1.23%
54,124 $13.2 Million
Q1 2022

Apr 20, 2022

BUY
$219.27 - $242.57 $777,312 - $859,910
3,545 Added 7.1%
53,469 $12.9 Million
Q4 2021

Jan 28, 2022

SELL
$198.88 - $227.6 $57,476 - $65,776
-289 Reduced 0.58%
49,924 $11.2 Million
Q3 2021

Nov 08, 2021

BUY
$212.27 - $248.7 $137,763 - $161,406
649 Added 1.31%
50,213 $10.7 Million
Q2 2021

Aug 05, 2021

BUY
$233.58 - $259.14 $362,516 - $402,185
1,552 Added 3.23%
49,564 $12.1 Million
Q1 2021

May 05, 2021

BUY
$221.91 - $258.6 $352,171 - $410,398
1,587 Added 3.42%
48,012 $11.9 Million
Q4 2020

Jan 26, 2021

BUY
$216.38 - $257.67 $513,469 - $611,450
2,373 Added 5.39%
46,425 $10.7 Million
Q3 2020

Nov 03, 2020

SELL
$234.65 - $260.95 $13,140 - $14,613
-56 Reduced 0.13%
44,052 $11.2 Million
Q2 2020

Jul 23, 2020

SELL
$197.81 - $242.74 $277,131 - $340,078
-1,401 Reduced 3.08%
44,108 $10.4 Million
Q1 2020

Apr 21, 2020

BUY
$182.24 - $241.7 $120,096 - $159,280
659 Added 1.47%
45,509 $9.23 Million
Q4 2019

Feb 10, 2020

BUY
$189.21 - $243.2 $181,452 - $233,228
959 Added 2.18%
44,850 $10.8 Million
Q3 2019

Nov 01, 2019

BUY
$174.11 - $208.62 $200,922 - $240,747
1,154 Added 2.7%
43,891 $8.49 Million
Q2 2019

Aug 07, 2019

BUY
$166.7 - $195.41 $268,720 - $315,000
1,612 Added 3.92%
42,737 $7.88 Million
Q1 2019

May 08, 2019

BUY
$180.87 - $203.88 $90,073 - $101,532
498 Added 1.23%
41,125 $7.81 Million
Q4 2018

Jan 25, 2019

BUY
$178.4 - $208.25 $55,482 - $64,765
311 Added 0.77%
40,627 $7.91 Million
Q3 2018

Oct 26, 2018

BUY
$185.29 - $208.89 $68,372 - $77,080
369 Added 0.92%
40,316 $8.36 Million
Q2 2018

Jul 25, 2018

BUY
$166.05 - $186.51 $148,448 - $166,739
894 Added 2.29%
39,947 $7.37 Million
Q1 2018

May 11, 2018

BUY
$169.43 - $198.0 $252,450 - $295,020
1,490 Added 3.97%
39,053 $6.66 Million
Q4 2017

Jan 30, 2018

BUY
$168.79 - $188.59 $234,449 - $261,951
1,389 Added 3.84%
37,563 $6.53 Million
Q3 2017

Oct 17, 2017

BUY
$167.29 - $191.0 $6.05 Million - $6.91 Million
36,174
36,174 $6.75 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $167B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Congress Asset Management CO Portfolio

Follow Congress Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Asset Management CO , based on Form 13F filings with the SEC.

News

Stay updated on Congress Asset Management CO with notifications on news.